You just read:

Bio Products Laboratory Presents New Phase 3 Data Demonstrating Prophylactic Coagadex® (Coagulation Factor X, Human) Dosing Prevents or Reduces Bleeding Episodes in Children with Moderate to Severe Hereditary Factor X Deficiency

News provided by

Bio Products Laboratory Limited

Jul 12, 2017, 08:15 ET